Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5H95B | — |
a twelve month old female patient was administered a Kinrix vaccine by mistake; a twelve month old female patient was administered a Kinrix vaccine by mistake; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 12-month-old female patient who received DTPa-IPV (Kinrix) (batch number 5H95B, expiry date 16-FEB-2026) for prophylaxis. Previously administered products included Dtp ipv vaccine (Received 2 doses on an unknown date). On 26-SEP-2024, the patient received Kinrix. On 26-SEP-2024, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: a twelve month old female patient was administered a Kinrix vaccine by mistake) and inappropriate schedule of vaccine administered (Verbatim: a twelve month old female patient was administered a Kinrix vaccine by mistake). The outcome of the inappropriate age at vaccine administration and inappropriate schedule of vaccine administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 30-JAN-2025 The reporter reported that a twelve month old female patient was administered a Kinrix vaccine by mistake which led to inappropriate age at vaccine administration and inappropriate schedule of vaccine administered. Reporter confirms this was the third dose of Dtap/IPV vaccination. No further information was obtained in this call.